
Yarrow Bioscience Inc
YARWHealthcare|Biotechnology|US
$15.60
+2.00 (+14.71%)
DCF Value
$23.72
Tangible Book / Share
$25.71
Cash / Share
$26.72
Ownership Breakdown
90.4%
Float
9.3M
Shares Outstanding
8.4M
Float Shares
Major Holders (37)
Combined: 264.8%
Holders of 5%+ from their latest Schedule 13D/13G filing in the last two years. Percentages are as of each filing date.
| Holder | Type | % of Class | Shares | Filed | Filing |
|---|---|---|---|---|---|
| Logos Global Management GP LLC | HC, OO | 10.70% | 286,308 | Aug 7, 2026 | 13D/G |
| Logos Global Management LP | IA, PN | 10.70% | 286,308 | Aug 7, 2026 | 13D/G |
| Arsani William | HC, IN | 10.70% | 286,308 | Aug 7, 2026 | 13D/G |
| Bellevue Group AG | HC, CO | 10.60% | 1,000,000 | Oct 7, 2026 | 13D/G |
| Bellevue Asset Management AG | Corporation | 10.60% | 1,000,000 | Oct 7, 2026 | 13D/G |
| venBio Global Strategic Fund V, L.P. | Partnership | 9.99% | 279,340 | Aug 14, 2026 | 13D/G |
| venBio Global Strategic GP V, LLC | HC, OO | 9.99% | 279,340 | Aug 14, 2026 | 13D/G |
| JANUS HENDERSON GROUP Ltd. | Holding company | 9.99% | 266,712 | Aug 7, 2026 | 13D/G |
| Perceptive Advisors LLC | Investment adviser | 9.99% | 266,756 | Aug 3, 2026 | 13D/G |
| Perceptive Life Sciences Master Fund, Ltd. | Corporation | 9.99% | 266,756 | Aug 3, 2026 | 13D/G |
| Joseph Edelman | Individual | 9.99% | 266,756 | Aug 3, 2026 | 13D/G |
| Roderick Wong | HC, IN | 9.99% | 266,307 | Jul 30, 2026 | 13D/G |
| RTW Fund Group GP, LLC | IA, HC | 9.99% | 266,307 | Jul 30, 2026 | 13D/G |
| Orbimed Advisors LLC | Investment adviser | 9.97% | 266,306 | Aug 5, 2026 | 13D/G |
| Daniel Schneeberger | HC, IN | 8.80% | 59,000 | Aug 14, 2026 | 13D/G |
| ADAR1 Capital Management, LLC | IA, OO | 8.80% | 59,000 | Aug 14, 2026 | 13D/G |
| OrbiMed Capital GP X, LP | Other | 8.73% | 233,019 | Aug 5, 2026 | 13D/G |
| OrbiMed Capital GP X LLC | Other | 8.73% | 233,019 | Aug 5, 2026 | 13D/G |
| Raymond Debbane | Individual | 7.20% | 675,000 | Sep 17, 2026 | 13D/G |
| Logos Global Master Fund LP | Partnership | 6.60% | 176,678 | Aug 7, 2026 | 13D/G |
| Logos GP LLC | HC, OO | 6.60% | 176,678 | Aug 7, 2026 | 13D/G |
| Invus Global Management, LLC | Other | 6.30% | 591,472 | Sep 17, 2026 | 13D/G |
| Invus Public Equities, L.P. | Partnership | 6.30% | 591,472 | Sep 17, 2026 | 13D/G |
| Siren, L.L.C. | Other | 6.30% | 591,472 | Sep 17, 2026 | 13D/G |
| Invus Public Equities Advisors, LLC | Other | 6.30% | 591,472 | Sep 17, 2026 | 13D/G |
| Len Blavatnik | Individual | 6.02% | 178,180 | Jul 29, 2026 | 13D/G |
| AI Biotechnology LLC | Other | 6.02% | 178,180 | Jul 29, 2026 | 13D/G |
| Access Industries Holdings LLC | Other | 6.02% | 178,180 | Jul 29, 2026 | 13D/G |
| Access Industries Management, LLC | Other | 6.02% | 178,180 | Jul 29, 2026 | 13D/G |
| Logos Opportunities Fund V LP | Partnership | 4.10% | 109,630 | Aug 7, 2026 | 13D/G |
| Graham Walmsley | HC, IN | 4.10% | 109,630 | Aug 7, 2026 | 13D/G |
| Logos Opportunities V GP LLC | HC, OO | 4.10% | 109,630 | Aug 7, 2026 | 13D/G |
| OrbiMed Genesis GP LLC | Other | 1.25% | 33,287 | Aug 5, 2026 | 13D/G |
| Avicenna Life Sci Master Fund LP | Partnership | 0.90% | 83,528 | Sep 17, 2026 | 13D/G |
| Avicenna Life Sci Master GP LLC | Other | 0.90% | 83,528 | Sep 17, 2026 | 13D/G |
| Ulys, L.L.C. | Other | 0.90% | 83,528 | Sep 17, 2026 | 13D/G |
| Zhang Xiaofan | Individual | 0.60% | 162,452 | Aug 13, 2026 | 13D/G |
Insider Trades (100)
Last 4 quarters: 1,290,094 acquired · 319,752 disposed
| Insider | Position | Date | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Payton Lori | Chief Development Officer | Oct 29, 2026 | AWARD | 99,827 | $20.00 | $2.0M | Form 4 |
| Alford Rachael | Chief Operating Officer | Oct 29, 2026 | AWARD | 89,844 | $20.00 | $1.8M | Form 4 |
| Frey Rebecca | director, officer: Chief Executive Officer | Oct 29, 2026 | AWARD | 465,857 | $20.00 | $9.3M | Form 4 |
| Ryder Steven | Chief Medical Officer | Oct 29, 2026 | AWARD | 113,137 | $20.00 | $2.3M | Form 4 |
| Zeronda Tyler | Chief Financial Officer | Oct 29, 2026 | AWARD | 156,115 | $20.00 | $3.1M | Form 4 |
| RTW Fund Group GP, LLC | 10 percent owner | Jul 29, 2026 | J | 133,290 | $0.00 | $13.33 | Form 4 |
| RTW Fund Group GP, LLC | 10 percent owner | Jul 29, 2026 | DISPOSED | 133,290 | — | — | Form 4 |
| RTW Fund Group GP, LLC | 10 percent owner | Jul 27, 2026 | OTHER | 0 | — | — | Form 4 |
| RTW Fund Group GP, LLC | 10 percent owner | Jul 27, 2026 | OTHER | 8,816,429 | $0.00 | $881.64 | Form 4 |
| Ashiya Mona | director | Jul 27, 2026 | AWARD | 15,435 | $28.56 | $440.8K | Form 4 |
| Zeronda Tyler | director | Jul 27, 2026 | AWARD | 185,798 | $28.56 | $5.3M | Form 4 |
| ORBIMED ADVISORS LLC | director | Jul 27, 2026 | OTHER | 0 | — | — | Form 4 |
| ORBIMED ADVISORS LLC | director | Jul 27, 2026 | OTHER | 0 | — | — | Form 4 |
| ORBIMED ADVISORS LLC | director | Jul 27, 2026 | OTHER | 583,545 | $0.00 | $58.35 | Form 4 |
| Ashiya Mona | director | Jul 27, 2026 | OTHER | 0 | — | — | Form 4 |
| Ashiya Mona | director | Jul 27, 2026 | OTHER | 0 | — | — | Form 4 |
| Ashiya Mona | director | Jul 27, 2026 | OTHER | 583,545 | $0.00 | $58.35 | Form 4 |
| White William Richard | director | Jul 27, 2026 | OTHER | 87,820 | $6.19 | $543.6K | Form 4 |
| Silverman Peter B. | director | Jul 27, 2026 | OTHER | 87,820 | $6.19 | $543.6K | Form 4 |
| Lundberg Sven Ante | director | Jul 27, 2026 | OTHER | 175,639 | $6.19 | $1.1M | Form 4 |
| Hoerter Steven L. | director | Jul 27, 2026 | OTHER | 87,820 | $6.19 | $543.6K | Form 4 |
| Alford Rachael | Chief Operating Officer | Jul 27, 2026 | OTHER | 175,639 | $6.19 | $1.1M | Form 4 |
| Payton Lori | Chief Development Officer | Jul 27, 2026 | OTHER | 175,639 | $6.19 | $1.1M | Form 4 |
| Ryder Steven | Chief Medical Officer | Jul 27, 2026 | OTHER | 228,330 | $6.19 | $1.4M | Form 4 |
| Frey Rebecca | director, officer: Chief Executive Officer | Jul 27, 2026 | OTHER | 878,194 | $6.19 | $5.4M | Form 4 |
| PERCEPTIVE ADVISORS LLC | 10 percent owner | Jul 27, 2026 | OTHER | 0 | — | — | Form 4 |
| PERCEPTIVE ADVISORS LLC | 10 percent owner | Jul 27, 2026 | OTHER | 967,360 | $0.00 | $96.74 | Form 4 |
| Zeronda Tyler | CHIEF FINANCIAL OFFICER | Jul 23, 2026 | TAX W/H | 22,516 | $0.90 | $20.2K | Form 4 |
| Stuart Iain | CHIEF SCIENTIFIC OFFICER | Jul 23, 2026 | TAX W/H | 15,405 | $0.90 | $13.8K | Form 4 |
| Harsch Mutya | CHIEF LEGAL OFFICER AND GC | Jul 23, 2026 | TAX W/H | 22,516 | $0.90 | $20.2K | Form 4 |
| Domzalski David | director, officer: PRESIDENT AND CEO | Jul 23, 2026 | TAX W/H | 79,391 | $0.90 | $71.3K | Form 4 |
| Zeronda Tyler | CHIEF FINANCIAL OFFICER | Jun 30, 2026 | TAX W/H | 3,464 | $0.65 | $2.3K | Form 4 |
| Stuart Iain | CHIEF SCIENTIFIC OFFICER | Jun 30, 2026 | TAX W/H | 2,370 | $0.65 | $1.5K | Form 4 |
| Harsch Mutya | CHIEF LEGAL OFFICER AND GC | Jun 30, 2026 | TAX W/H | 3,464 | $0.65 | $2.3K | Form 4 |
| Domzalski David | director, officer: PRESIDENT AND CEO | Jun 30, 2026 | TAX W/H | 12,214 | $0.65 | $7.9K | Form 4 |
| Domzalski David | director, officer: PRESIDENT AND CEO | May 29, 2026 | AWARD | 30,791 | $0.31 | $9.5K | Form 4 |
| Zeronda Tyler | CHIEF FINANCIAL OFFICER | Mar 31, 2026 | TAX W/H | 4,007 | $0.60 | $2.4K | Form 4 |
| Stuart Iain | CHIEF SCIENTIFIC OFFICER | Mar 31, 2026 | TAX W/H | 2,876 | $0.60 | $1.7K | Form 4 |
| Harsch Mutya | CHIEF LEGAL OFFICER AND GC | Mar 31, 2026 | TAX W/H | 4,007 | $0.60 | $2.4K | Form 4 |
| Domzalski David | director, officer: PRESIDENT AND CEO | Mar 31, 2026 | TAX W/H | 14,232 | $0.60 | $8.5K | Form 4 |
| Domzalski David | director, officer: PRESIDENT AND CEO | Dec 31, 2025 | TAX W/H | 12,684 | $0.58 | $7.4K | Form 4 |
| Zeronda Tyler | CHIEF FINANCIAL OFFICER | Dec 31, 2025 | TAX W/H | 7,858 | $0.58 | $4.6K | Form 4 |
| Stuart Iain | CHIEF SCIENTIFIC OFFICER | Dec 31, 2025 | TAX W/H | 2,448 | $0.58 | $1.4K | Form 4 |
| Harsch Mutya | CHIEF LEGAL OFFICER AND GC | Dec 31, 2025 | TAX W/H | 3,579 | $0.58 | $2.1K | Form 4 |
| Little Elisabeth Sandoval | director | Dec 12, 2025 | AWARD | 20,000 | $0.38 | $7.5K | Form 4 |
| LEPORE PATRICK G | director | Dec 12, 2025 | AWARD | 20,000 | $0.38 | $7.5K | Form 4 |
| Basta Steven L | director | Dec 12, 2025 | AWARD | 20,000 | $0.38 | $7.5K | Form 4 |
| BARBARI SHARON | director | Dec 12, 2025 | AWARD | 20,000 | $0.38 | $7.5K | Form 4 |
| Zeronda Tyler | CHIEF FINANCIAL OFFICER | Sep 30, 2025 | TAX W/H | 3,420 | $0.34 | $1.1K | Form 4 |
| Stuart Iain | CHIEF SCIENTIFIC OFFICER | Sep 30, 2025 | TAX W/H | 2,453 | $0.34 | $821.75 | Form 4 |
| Harsch Mutya | CHIEF LEGAL OFFICER AND GC | Sep 30, 2025 | TAX W/H | 3,581 | $0.34 | $1.2K | Form 4 |
| Domzalski David | director, officer: PRESIDENT AND CEO | Sep 30, 2025 | TAX W/H | 12,676 | $0.34 | $4.2K | Form 4 |
| Zeronda Tyler | CHIEF FINANCIAL OFFICER | Jun 30, 2025 | TAX W/H | 3,420 | $1.65 | $5.6K | Form 4 |
| Stuart Iain | CHIEF SCIENTIFIC OFFICER | Jun 30, 2025 | TAX W/H | 2,453 | $1.65 | $4.0K | Form 4 |
| Harsch Mutya | CHIEF LEGAL OFFICER AND GC | Jun 30, 2025 | TAX W/H | 3,581 | $1.65 | $5.9K | Form 4 |
| Domzalski David | director, officer: PRESIDENT AND CEO | Jun 30, 2025 | TAX W/H | 12,676 | $1.65 | $20.9K | Form 4 |
| Harsch Mutya | CHIEF LEGAL OFFICER AND GC | Jun 2, 2025 | AWARD | 1,145 | $0.81 | $927.45 | Form 4 |
| Domzalski David | director, officer: PRESIDENT AND CEO | Jun 2, 2025 | AWARD | 8,681 | $0.81 | $7.0K | Form 4 |
| Zeronda Tyler | CHIEF FINANCIAL OFFICER | Mar 31, 2025 | TAX W/H | 8,399 | $1.58 | $13.3K | Form 4 |
| Stuart Iain | CHIEF SCIENTIFIC OFFICER | Mar 31, 2025 | TAX W/H | 6,044 | $1.58 | $9.5K | Form 4 |
| Harsch Mutya | CHIEF LEGAL OFFICER AND GC | Mar 31, 2025 | TAX W/H | 8,828 | $1.58 | $13.9K | Form 4 |
| Domzalski David | director, officer: PRESIDENT AND CEO | Mar 31, 2025 | TAX W/H | 30,498 | $1.58 | $48.2K | Form 4 |
| Zeronda Tyler | CHIEF FINANCIAL OFFICER | Jan 21, 2025 | AWARD | 230,000 | $2.77 | $637.1K | Form 4 |
| Stuart Iain | CHIEF SCIENTIFIC OFFICER | Jan 21, 2025 | AWARD | 230,000 | $2.77 | $637.1K | Form 4 |
| Harsch Mutya | CHIEF LEGAL OFFICER AND GC | Jan 21, 2025 | AWARD | 230,000 | $2.77 | $637.1K | Form 4 |
| Domzalski David | director, officer: PRESIDENT AND CEO | Jan 21, 2025 | AWARD | 730,000 | $2.77 | $2.0M | Form 4 |
| LEPORE PATRICK G | director | Jan 15, 2025 | BUY | 15,000 | $2.92 | $43.8K | Form 4 |
| Zeronda Tyler | CHIEF FINANCIAL OFFICER | Dec 31, 2024 | TAX W/H | 4,675 | $3.35 | $15.7K | Form 4 |
| Stuart Iain | CHIEF SCIENTIFIC OFFICER | Dec 31, 2024 | TAX W/H | 4,857 | $3.35 | $16.3K | Form 4 |
| Harsch Mutya | CHIEF LEGAL OFFICER AND GC | Dec 31, 2024 | TAX W/H | 4,697 | $3.35 | $15.7K | Form 4 |
| Domzalski David | director, officer: PRESIDENT AND CEO | Dec 31, 2024 | TAX W/H | 24,536 | $3.35 | $82.2K | Form 4 |
| Borowski Christine | director | Dec 12, 2024 | AWARD | 20,000 | $2.40 | $48.0K | Form 4 |
| LEPORE PATRICK G | director | Dec 12, 2024 | AWARD | 20,000 | $2.40 | $48.0K | Form 4 |
| Basta Steven L | director | Dec 12, 2024 | AWARD | 20,000 | $2.40 | $48.0K | Form 4 |
| BARBARI SHARON | director | Dec 12, 2024 | AWARD | 20,000 | $2.40 | $48.0K | Form 4 |
| Sandoval Elisabeth | director | Dec 12, 2024 | AWARD | 20,000 | $2.40 | $48.0K | Form 4 |
| Bruno Anthony D | director | Dec 12, 2024 | AWARD | 20,000 | $2.40 | $48.0K | Form 4 |
| Domzalski David | director, officer: PRESIDENT AND CEO | Nov 30, 2024 | AWARD | 3,901 | $2.10 | $8.2K | Form 4 |
| Zeronda Tyler | CHIEF FINANCIAL OFFICER | Sep 30, 2024 | TAX W/H | 84 | $1.88 | $157.92 | Form 4 |
| Stuart Iain | CHIEF SCIENTIFIC OFFICER | Sep 30, 2024 | TAX W/H | 109 | $1.88 | $204.92 | Form 4 |
| Domzalski David | director, officer: PRESIDENT AND CEO | Sep 30, 2024 | TAX W/H | 685 | $1.88 | $1.3K | Form 4 |
| Harsch Mutya | CHIEF LEGAL OFFICER AND GC | Sep 30, 2024 | TAX W/H | 105 | $1.88 | $197.40 | Form 4 |
| Zeronda Tyler | CHIEF FINANCIAL OFFICER | Jul 1, 2024 | TAX W/H | 92 | $1.92 | $176.64 | Form 4 |
| Stuart Iain | CHIEF SCIENTIFIC OFFICER | Jul 1, 2024 | TAX W/H | 138 | $1.92 | $264.96 | Form 4 |
| Harsch Mutya | CHIEF LEGAL OFFICER AND GC | Jul 1, 2024 | TAX W/H | 143 | $1.92 | $274.56 | Form 4 |
| Domzalski David | director, officer: PRESIDENT AND CEO | Jul 1, 2024 | TAX W/H | 935 | $1.92 | $1.8K | Form 4 |
| Domzalski David | director, officer: PRESIDENT AND CEO | May 31, 2024 | AWARD | 4,429 | $2.16 | $9.6K | Form 4 |
| Zeronda Tyler | CHIEF FINANCIAL OFFICER | Apr 1, 2024 | TAX W/H | 94 | $3.08 | $289.52 | Form 4 |
| Stuart Iain | CHIEF SCIENTIFIC OFFICER | Apr 1, 2024 | TAX W/H | 157 | $3.08 | $483.56 | Form 4 |
| Harsch Mutya | CHIEF LEGAL OFFICER AND GC | Apr 1, 2024 | TAX W/H | 161 | $3.08 | $495.88 | Form 4 |
| Domzalski David | director, officer: PRESIDENT AND CEO | Apr 1, 2024 | TAX W/H | 1,004 | $3.08 | $3.1K | Form 4 |
| Zeronda Tyler | Chief Financial Officer | Jan 1, 2024 | AWARD | 62,500 | — | — | Form 4 |
| Zeronda Tyler | Chief Financial Officer | Jan 2, 2024 | TAX W/H | 93 | $2.28 | $212.04 | Form 4 |
| Zeronda Tyler | Chief Financial Officer | Jan 1, 2024 | AWARD | 62,500 | $2.33 | $145.6K | Form 4 |
| Stuart Iain | Chief Scientific Officer | Jan 1, 2024 | AWARD | 62,500 | — | — | Form 4 |
| Stuart Iain | Chief Scientific Officer | Jan 2, 2024 | TAX W/H | 157 | $2.28 | $357.96 | Form 4 |
| Stuart Iain | Chief Scientific Officer | Jan 1, 2024 | AWARD | 62,500 | $2.33 | $145.6K | Form 4 |
| Harsch Mutya | Chief Legal Officer and GC | Jan 1, 2024 | AWARD | 62,500 | — | — | Form 4 |
| Harsch Mutya | Chief Legal Officer and GC | Jan 2, 2024 | TAX W/H | 161 | $2.28 | $367.08 | Form 4 |
| Harsch Mutya | Chief Legal Officer and GC | Jan 1, 2024 | AWARD | 62,500 | $2.33 | $145.6K | Form 4 |